$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Once the technique has been performed and cells are loaded with dextran and ready for analysis (Figure 1), ensure the flow cytometer is not blocked and adjust the forward scatter/side scatter profile to look like the cells shown in Figure 2A. If the machine is blocked, it will look more like that shown in Figure 2B and must be unblocked before continuing. Ensure the parameters show control axenic cells have high internalized dextran fluorescence at longer time points and low internalized fluorescence at shorter ones (Figure 2C).
When looking for differences between mutants, it is likely that there will be one of three phenotypes. The mutants could have normal fluid uptake, they could have a partial defect, or fluid uptake could be completely abolished. Figure 2D shows a strain with normal fluid uptake, in this case the standard laboratory strain Ax2, a mutant with a ~50% decrease in fluid uptake (Ax2 rasG-14) and one with abolished fluid uptake (Ax3 gefB-28). Obtain the average median fluid uptake (section 3.5) and use it to either calculate the volume of fluid internalized (as in Figure 3B) or compare the data to a control (as in Figure 4B and 4C).
When performing a fluid uptake time course, as in Figure 3A, the internalized fluorescence should increase for 60–90 min, after which the dextran begins to be exocytosed and a plateau is reached (Figure 3B). Using 60 min as the standard time point when comparing macropinocytosis in different mutants/conditions therefore allows a good signal to be achieved, and no signal is lost due to exocytosis. Mutants where exocytosis is severely obstructed may take longer to reach a plateau29.
When treating cells with inhibitors that are effective against macropinocytosis in Dictyostelium (set up as in Figure 4A), the dextran internalized in 1 h will go down to almost nothing at higher inhibitor concentrations in the majority of cases (Figure 4B). Some inhibitors may not be 100% effective, however, e.g. nocodazole only inhibits up to 50% of fluid uptake by macropinocytosis when added acutely (Figure 4C). If the inhibitors are not effective, the cells will internalize a similar amount of dextran as the control, and a decrease in fluorescence will not be seen. This technique allows a large range of different inhibitors and inhibitor concentrations to be screened for effects on fluid uptake by macropinocytosis very quickly, reducing the time spent optimizing the inhibitor treatment.

Figure 2: Set up of flow cytometer and representative data. (A) The forward scatter (FSC) and side scatter (SSC) profiles of cells should be set so the cells can be easily distinguished. An example of how Ax2 cells should look is shown. (B) If the flow cytometer is blocked, as in this example, the cells have very low side scatter. The laser will not excite the fluorophores properly and the machine should be unblocked before continuing. Any data obtained while the machine was blocked should be discarded. (C) The fluorescence should be set so that a 0 min uptake sample has low fluorescence, which increases when cells have been incubated for longer in the fluorescent medium, as shown in this example taken from Williams & Kay 201824. (D) Examples of cells that have been incubated with TRITC dextran for 1 h with normal macropinocytosis (Ax2, green), reduced macropinocytosis (Ax2 rasG-, HM172614, orange) and abolished macropinocytosis (Ax3 gefB-, HM177628, blue). Please click here to view a larger version of this figure.

Figure 3: Performing fluid uptake time-courses in 96-well plates. (A) Dextran should be added to each set of samples sequentially, with the same finish time. Then wash the wells, detach and measure the internalized fluorescence by flow cytometry. Example times to add the dextran are shown here. (B) Fluid uptake time-course of Ax2 cells performed in 96-well plates. Taken from Williams & Kay 201824, error bars show the standard error of three independent experiments. Please click here to view a larger version of this figure.

Figure 4: Fluid uptake dose response curves. (A) Add the compound of interest, in this case the PI3K inhibitor LY294002, to HL5 containing 1 mg/mL TRITC-dextran at double the desired final maximum concentration. Mix with HL5 growth medium + 1 mg/mL dextran containing vehicle alone in various proportions to generate a dilution series of 200 µL medium per condition. Add to wells as normal for 1 h before washing and measuring internalized fluorescence. (B) Fluid uptake dose response curve for Ax2 cells incubated with the LY294002-containing medium from A. Adapted from Williams & Kay 201824. Fluid uptake is normalized to an untreated control. Error bars show the standard error of three independent experiments. (C) Fluid uptake dose response curve for Ax2 cells incubated with the nocodazole. Adapted from Williams & Kay 201824. Fluid uptake is normalized to an untreated control. Error bars show the standard error of three independent experiments. Please click here to view a larger version of this figure.